Genus plc (LON:GNS - Get Free Report) shares passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,818.83 ($23.55) and traded as high as GBX 1,970 ($25.50). Genus shares last traded at GBX 1,952 ($25.27), with a volume of 7,896,197 shares.
Analyst Upgrades and Downgrades
Separately, Shore Capital reiterated a "buy" rating on shares of Genus in a research note on Wednesday, December 11th.
Check Out Our Latest Analysis on GNS
Genus Price Performance
The stock has a market capitalization of £1.24 billion, a P/E ratio of 157.16, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The company has a debt-to-equity ratio of 53.12, a current ratio of 1.80 and a quick ratio of 1.08. The stock has a fifty day moving average price of GBX 1,853.39 and a 200 day moving average price of GBX 1,820.50.
Genus (LON:GNS - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported GBX 39.80 ($0.52) EPS for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. On average, research analysts forecast that Genus plc will post 70.9644323 earnings per share for the current year.
Insiders Place Their Bets
In other Genus news, insider Jorgen Kokke sold 19,967 shares of the company's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of GBX 1,731 ($22.41), for a total value of £345,628.77 ($447,473.81). Corporate insiders own 0.75% of the company's stock.
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Read More
Before you consider Genus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.
While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
